Skip to main content
    A

    Akebia Ther (AKBA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.40
    -0.05 (-10.74%)

    Market Cap: $131.67M

    Last updated: Nov 17, 2026 at 4:38 PM ET

    Akebia Ther (AKBA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Akebia Ther (AKBA) has a market cap of $131.67M and an enterprise value of $22.68M. It holds $108.98M more cash than debt, 82.77% of its market cap. Its share count is up 4.56% from a year earlier.

    Total Valuation

    Enterprise value is 82.77% below the market cap, as cash exceeds debt.

    Market Cap$131.67M
    Enterprise Value$22.68M
    Latest price (Nov 17, 2026)$0.40

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 2.69% in the quarter ended Sep 30, 2026 and grew 14.73% a year over 2 years.

    Shares Outstanding276.86M
    Shares Change (YoY)+4.56%
    Shares Change (QoQ)+2.69%
    Share Count Growth (2Y CAGR)+14.73%

    Valuation Ratios

    Sales and book value multiples are 0.6x and 5.4x. Its year-end P/S ranged from 1.2x to 262.9x from 2016 to 2025.

    P/S Ratio0.6x
    Forward P/S0.8x
    P/B Ratio5.4x
    P/FCF Ratio8.0x
    P/OCF Ratio8.3x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 0.1x free cash flow.

    EV / Sales0.1x
    EV / FCF0.1x

    Price Statistics

    The stock is down 76.02% over 52 weeks and trades 46.67% below its 50-day average.

    Beta (1Y)2.78
    52-Week Change-76.02%
    1-Month Change-41.13%
    3-Month Change-54.78%
    6-Month Change-55.27%
    5-Year Change-75.38%
    10-Year Change-90.61%
    Total Return (1Y)-76.02%
    Total Return (3Y CAGR)-26.29%
    Total Return (5Y CAGR)-32.05%
    Max Drawdown (1Y)-77.25%
    Max Drawdown (3Y)-90.01%
    Sharpe Ratio (1Y)-1.50
    Correlation with SPY (1Y)0.40
    50-Day Average$0.75
    200-Day Average$1.09
    52-Week Range$0.36 to $1.73
    RSI (14 Days)32.5
    Average Volume (20 Days)8.60M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.36x current liabilities, and total debt is 2.47x shareholder equity.

    Current Ratio1.36x
    Quick Ratio1.24x
    Debt / Equity2.47x
    Debt / FCF3.63x

    Returns and Efficiency

    Return on invested capital is -38.86% and return on equity is -218.76% over the last 12 months.

    Return on Equity (ROE)-218.76%
    Return on Assets (ROA)-13.02%
    Return on Invested Capital (ROIC)-38.86%
    Return on Capital Employed (ROCE)-15.27%
    ROA (5Y Average)-26.82%
    Asset Turnover0.56x
    Inventory Turnover2.62x
    Receivables Turnover4.38x
    Cash Conversion Cycle148 days

    Scores

    AKBA has an Altman Z-Score of -6.30, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score-6.30
    Altman Z ZoneDistress
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $197.20M over the last 12 months is down 12.38% from the 12 months before.

    Revenue$197.20M
    Revenue Growth (YoY)-12.38%
    Gross Profit$155.59M
    Operating Income-$31.04M
    Pretax Income-$43.18M
    Net Income-$44.56M
    EBITDA-$26.11M
    EBIT-$27.45M
    Reported EPS (TTM)-$0.14

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 5.95% of the $342.13M in total assets.

    Cash and Equivalents$159.25M
    Total Debt$50.27M
    Net Cash$108.98M
    Net Cash Per Share$0.39
    Working Capital$58.44M
    Shareholder Equity$20.37M
    Book Value Per Share$0.07
    Tangible Book Value-$38.67M
    Total Assets$342.13M
    Total Liabilities$321.76M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $1.92M of capital spending, operating cash flow left $13.86M of free cash flow.

    Operating Cash Flow$15.78M
    Capital Expenditures$1.92M
    Free Cash Flow$13.86M
    FCF Per Share$0.05
    Depreciation and Amortization$1.33M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -15.74%, against a 5-year average of -39.58%.

    Gross Margin78.90%
    Operating Margin-15.74%
    Pretax Margin-21.90%
    Net Margin-22.60%
    EBITDA Margin-13.24%
    EBIT Margin-13.92%
    FCF Margin7.03%
    Gross Margin (5Y Average)61.06%
    Operating Margin (5Y Average)-39.58%
    Net Margin (5Y Average)-47.55%

    Growth

    Revenue fell 6.88% a year over 3 years.

    Revenue Growth (3Y CAGR)-6.88%
    Revenue Growth (5Y CAGR)-4.33%

    Revenue and profit by year

    Dividends and Yields

    AKBA does not pay a dividend. Its free cash flow yield is 12.50%.

    FCF Yield12.50%
    Buyback Yield-9.04%
    Shareholder Yield-9.04%

    Peer Position

    Against 8 similar companies, AKBA has the 6th highest P/S.

    P/S Ratio0.6x vs 1.5x median
    ROIC-38.86% vs -3.84% median
    Revenue Growth (Trailing 4 Quarters, YoY)-12.38% vs +11.40% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -33.47% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-33.47%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About AKBA

    What is AKBA's market cap?

    Akebia Ther has a market cap of $131.67M. Its enterprise value, which adds debt and subtracts cash, is $22.68M.

    How many shares of AKBA are outstanding?

    Akebia Ther has 276.86M shares outstanding. The count is up 4.56% from a year earlier.

    Does AKBA pay a dividend?

    No. Akebia Ther does not pay a dividend.

    How much debt does AKBA have?

    Akebia Ther has $50.27M of total debt and $159.25M of cash and equivalents, a net cash position of $108.98M.